PHORBOL ESTER RESPONSIVE B LYMPHOCYTES
PHORBOL ESTER RESPONSIVE B LYMPHOCYTES
批准号:
3144588
负责人:
THOMAS L ROTHSTEIN
金额:
$23.59万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-04-01 至 1993-03-31
关键词:
B lymphocyte antiantibody biological signal transduction cell growth regulation diacylglycerols flow cytometry gene expression immunoglobulins inositol phosphates isozymes laboratory mouse leukocyte activation /transformation lymphocyte proliferation membrane proteins oncogenes phorbols protein kinase C second messengers tissue /cell culture
中文摘要
这项拟议研究的目标是了解Ly-1系B细胞是如何
刺激增殖并阐明细胞内机制
负责S在这些单元格中的阶段进入。(1)在第一个具体项目中
目的我们将扩展我们以前的工作,表明Ly-1+B细胞是
独一无二地被刺激以启动佛波酯的DNA合成,而不需要
共有丝分裂原,通过更充分地探索佛波酯的性质
有反应的B细胞。将检查反应性B细胞的表型
预激活的问题将通过评估
B细胞激活的标志。(2)在第二个具体问题中
目的我们将探索细胞内的机制,它负责
佛波酯诱导Ly-1+B细胞进入S时相。初步结果
建议蛋白激酶C发挥核心作用。我们将评估PKC活性
和同工酶,特别注意佛波酯之间的差异
反应性(Ly-1+)和无反应性(常规)B细胞。到时候我们会的
开始将PKC活动与“下游”事件联系起来,通过确定
C-myc、c-fos和c-jun 3个早期反应基因的刺激表达--
并通过鉴定可能调节基因的Fos相关蛋白
表达及我们发现Ly-1+B细胞不能通过
通过确定SLG中介的信号被颠覆的级别来签名。
我们将通过测量IP3的产量来评估第二代信使
和DAG以及PKC的易位,我们将检查更远端的
早期反应基因表达的事件。LY-1+B细胞产生
自身抗体与自身免疫的发病机制有关
疾病;Ly-1+B细胞容易发生肿瘤性转化和
代表了许多B细胞肿瘤的起源细胞。澄清:
控制Ly-1+B细胞增殖的机制可能有助于理解
淋巴细胞自身免疫性疾病和恶性疾病的起源及建议
影响其结果的手段。
英文摘要
The goal of the proposed studies is to learn how Ly-1 lineage B cells are
stimulated to proliferate and to elucidate the intracellular mechanisms
responsible for S phase entry in these cells. (1) In the first specific
aim we will extend our previous work showing that Ly-1+ B cells are
uniquely stimulated to initiate DNA synthesis by phorbol ester, without a
co-mitogen, by more fully exploring the nature of the phorbol ester
responsive B cell. The phenotype of responsive B cells will be examined
and the issue of pre-activation will be addressed through evaluation of
markers that are signs of B cell activation. (2) In the second specific
aim we will explore the intracellular mechanisms that are responsible for
phorbol ester induced S phase entry in Ly-1+ B cells. Preliminary results
suggest a central role for protein kinase C. We will evaluate PKC activity
and isozymes with particular attention to difference between phorbol ester
responsive (Ly-1+) and nonresponsive (conventional) B cells. We will then
begin to link PKC activity with "downstream" events by determining the
stimulated expression of 3 early response gene--c-myc, c-fos, and c-jun--
and by characterizing Fos associated proteins that may regulate gene
expression and our finding that Ly-1+ B cells fail to be stimulated through
sIg by identifying the level at which sLg mediated signaling is subverted.
We will evaluate second messenger generation by measuring production of IP3
and DAG and translocation of PKC, and we will examine the more distal
events of early response gene expression. Ly-1+ B cells produce
autoantibodies and are implicated in the pathogenesis of autoimmune
diseases; ly-1+ B cells readily undergo neoplastic transformation and
represent the cell of origin for many B cell tumors. Elucidation of the
mechanisms that govern Ly-1+ B cells proliferation may aid in understanding
the origin of autoimmune and malignant diseases of lymphocytes and suggest
means of influencing their outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FAIM Proteostasis in ALS
-
批准号:10527540
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2022
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1-like Cells and Pneumococcal Defense in the Elderly
-
批准号:10553643
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2019
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1-like Cells and Pneumococcal Defense in the Elderly
-
批准号:10330573
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2019
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
IgM vs IgG natural antibodies that bind pathogenic apolipoprotein B100
-
批准号:9305007
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2016
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Lymphopoiesis
-
批准号:8385892
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Lymphopoiesis
-
批准号:8496698
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Cell Immunoglobulin
-
批准号:8521076
-
项目类别:
-
资助金额:$7.92万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Cell Immunoglobulin
-
批准号:8284733
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8081080
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8489252
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:7987067
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8289406
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8689885
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:8282872
-
项目类别:
-
资助金额:$40.67万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:7936838
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
B1 Cell Induction of TH17 Cell Differentiation
-
批准号:7661078
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:7582935
-
项目类别:
-
资助金额:$46.58万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
B1 Cell Induction of TH17 Cell Differentiation
-
批准号:7774358
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:8488386
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:8099789
-
项目类别:
-
资助金额:$40.67万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位: